Eton Pharmaceuticals (ETON) Other Non-Current Assets (2017 - 2025)
Eton Pharmaceuticals (ETON) reported Other Non-Current Assets of $19000.0 for Q4 2025, up 58.33% on a YoY basis from $12000.0 in Q4 2024, and little changed sequentially from $19000.0 in Q3 2025.
Eton Pharmaceuticals (ETON) Other Non-Current Assets (2017 - 2025) Analysis & Trends
Eton Pharmaceuticals (ETON) has 9 years of Other Non-Current Assets data on file, last reported at $19000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Non-Current Assets rose 58.33% year-over-year to $19000.0; the trailing twelve-month figure through Dec 2025 stood at $19000.0 (up 58.33% YoY), and the FY2025 full-year result was $19000.0, up 58.33% from the prior year.
- Other Non-Current Assets steadied at $19000.0 in Q4 2025, from $19000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $36000.0 in Q1 2021 to a low of $12000.0 in Q1 2022.
- A 5-year average of $15900.0 and a median of $12000.0 in 2022 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets tumbled 71.6% in 2021 and soared 58.33% in 2025, its largest moves.
- Tracing ETON's Other Non-Current Assets over 5 years: stood at $21000.0 in 2021, then sank by 42.86% to $12000.0 in 2022, then changed by 0.0% to $12000.0 in 2023, then changed by 0.0% to $12000.0 in 2024, then soared by 58.33% to $19000.0 in 2025.
- Business Quant data shows ETON's Other Non-Current Assets at $19000.0 in Q4 2025, $19000.0 in Q3 2025, and $12000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Eton Pharmaceuticals | 1.19 Bn | 1.16 Bn | 13.10 Mn | 19,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19,000.00 |
| Sep 30, 2025 | 19,000.00 |
| Jun 30, 2025 | 12,000.00 |
| Mar 31, 2025 | 12,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Dec 31, 2023 | 12,000.00 |
| Sep 30, 2023 | 12,000.00 |
| Jun 30, 2023 | 12,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Dec 31, 2022 | 12,000.00 |
| Sep 30, 2022 | 12,000.00 |
| Jun 30, 2022 | 12,000.00 |
| Mar 31, 2022 | 12,000.00 |
| Dec 31, 2021 | 21,000.00 |
| Sep 30, 2021 | 23,000.00 |
| Jun 30, 2021 | 32,000.00 |
| Mar 31, 2021 | 36,000.00 |